Heart rate variability in children with breath holding spells and the role of iro
Phase 4
Recruiting
- Conditions
- Paediatrics
- Registration Number
- PACTR201907632829653
- Lead Sponsor
- faculty of medicine of tanta university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
infants and children with BHS not associated with any neurological or cardiological problems.
Exclusion Criteria
children with congenital or acquired heart disease, children with any neurological illness, drug intake, and positive family history of neurological illness, or cardiac problems.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link iron deficiency to heart rate variability in children with breath holding spells?
How does iron supplementation compare to standard-of-care for managing breath holding spells in paediatrics?
Are there specific biomarkers that predict response to iron therapy in children with breath holding spells?
What adverse events are associated with iron treatment in paediatric patients with breath holding spells?
What combination therapies involving iron are being explored for breath holding spells in children?